JENNIFER KEMMERER: Open Payments
NPI 1700880515 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 27 payments from 8 companies in 2025. Trend: 2023 $762 · 2024 $724 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $148 |
| ABBVIE INC. | 10 | $147 |
| Dexcom, Inc. | 4 | $96 |
| Amgen Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| Exact Sciences Corporation | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: JARDIANCE, Dexcom G6 Transmitter, QULIPTA, OTEZLA, TRELEGY ELLIPTA, VRAYLAR, AREXVY, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
